Government oversight affects every aspect of the healthcare industry, from construction of new healthcare facilities, to payment for medical services and the buying and selling of healthcare businesses. With multiple regulatory bodies governing the healthcare industry at state and federal levels — often with overlapping authority — providers, investors and healthcare service providers must juggle numerous, constantly changing regulations and policies.
McGuireWoods’ attorneys have the knowledge and experience healthcare providers need to assess and achieve compliance with federal and state-specific regulatory requirements. This group of more than 53 healthcare-focused attorneys advises clients on a range of regulatory and policy issues, including:
McGuireWoods takes full advantage of the firm’s national network of 20 offices to advise clients on compliance with local, state and federal regulations in jurisdictions throughout the United States. Given the rate of change and level of uncertainty in this highly regulated industry, we update our clients regularly on national and local trends and pending legislation via frequent client alerts, newsletters and blogs, including The Healthcare Investor and The FCA Insider.
Representative matters include:
Partner
Partner
Partner
Sr. VP, Federal Public Affairs, McGuireWoods Consulting LLC
HHS Proposes Eliminating Mandatory Notices, Gender Identity Protections From Nondiscrimination Rules
May 30, 2019
CMS Revised Guidance on Immediate Jeopardy
May 24, 2019
Pay for Delay Passes House of Representatives for First Time
May 22, 2019
HHS OIG Issues Proposed Rule Altering AKS Safe Harbor for Pharmacy Benefit Manager Rebates
March 12, 2019
CMS Revises Medicare Manual to Improve Transparency of LCD Process
October 16, 2018